Search Results - "Schmid, Herbert A"
-
1
Improving Oral Bioavailability of Peptides by Multiple N-Methylation: Somatostatin Analogues
Published in Angewandte Chemie (International ed.) (25-03-2008)“…Full methyl jacket? A complete library of the N‐methylated somatostatin cyclopeptidic analogue Veber–Hirschmann peptide cyclo(‐PFwKTF‐) has been prepared with…”
Get full text
Journal Article -
2
Effects of somatostatin analogs on glucose homeostasis in rats
Published in Journal of endocrinology (01-01-2012)“…Pasireotide (SOM230) is a multireceptor-targeted somatostatin analog with high binding affinity for sstr1,2,3 and sstr5. The effects of pasireotide and…”
Get full text
Journal Article -
3
Opportunities in somatostatin research: biological, chemical and therapeutic aspects
Published in Nature reviews. Drug discovery (01-12-2003)“…Somatostatins -- also known as somatotropin-release inhibiting factors (SRIFs) -- are a family of cyclopeptides that have broad inhibitory effects on the…”
Get full text
Journal Article -
4
Lung volume quantified by MRI reflects extracellular-matrix deposition and altered pulmonary function in bleomycin models of fibrosis: effects of SOM230
Published in American journal of physiology. Lung cellular and molecular physiology (15-06-2014)“…Idiopathic pulmonary fibrosis is a progressive and lethal disease, characterized by loss of lung elasticity and alveolar surface area, secondary to alveolar…”
Get more information
Journal Article -
5
Somatostatin receptor activation is involved in the control of daily torpor in a seasonal mammal
Published in American journal of physiology. Regulatory, integrative and comparative physiology (15-09-2015)“…Siberian hamsters (Phodopus sungorus) show spontaneous daily torpor only after ∼2 mo in winter-like short photoperiods (SP). Although some SP-induced hormonal…”
Get more information
Journal Article -
6
Functional activity of the multiligand analog SOM230 at human recombinant somatostatin receptor subtypes supports its usefulness in neuroendocrine tumors
Published in Neuroendocrinology (2004)“…Functional gastroenteropancreatic tumors express all 5 somatostatin receptor subtypes (sst) in different quantities. Octreotide and lanreotide treat patients…”
Get more information
Journal Article -
7
Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors
Published in Future oncology (London, England) (01-07-2011)“…Somatostatin receptors (sstrs) are G-protein-coupled receptors that mediate various physiological effects when activated by the neuropeptide somatostatin or…”
Get more information
Journal Article -
8
Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model
Published in Surgery (01-12-2012)“…Background Pasireotide (SOM230), a long-acting somatostatin analogue (LAR), has improved agonist activity at somatostatin receptors. We tested the effect of…”
Get full text
Journal Article -
9
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion
Published in Endocrine-related cancer (01-03-2007)“…Somatostatin (SRIF) analogs have been employed in medical therapy of non-functioning pituitary adenomas (NFA), with contrasting results. Previous evidence…”
Get full text
Journal Article -
10
The Somatostatin Analog SOM230 (Pasireotide) Ameliorates Injury of the Intestinal Mucosa and Increases Survival after Total-Body Irradiation by Inhibiting Exocrine Pancreatic Secretion
Published in Radiation research (01-06-2009)“…Fu, Q., Berbée, M., Boerma, M., Wang, J., Schmid, H. A. and Hauer-Jensen, M. The Somatostatin Analog SOM230 (Pasireotide) Ameliorates Injury of the Intestinal…”
Get full text
Journal Article -
11
Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohistochemical application in neuroendocrine tumors
Published in Neuroendocrinology (01-01-2012)“…Activation of somatostatin receptors (sstr1-5) by somatostatin and its analogues exerts an inhibitory effect on hormone secretion and provides the basis for…”
Get more information
Journal Article -
12
Preclinical Evaluation of SOM230 as a Radiation Mitigator in a Mouse Model: Postexposure Time Window and Mechanisms of Action
Published in Radiation research (01-06-2011)“…The somatostatin analog SOM230 has potent radioprophylactic and radiation mitigating properties that are unrelated to cytoprotection but appear to be due to…”
Get full text
Journal Article -
13
Site-specific effects of ghrelin on the neuronal activity in the hypothalamic arcuate nucleus
Published in Neuroscience letters (01-05-2003)“…The recently discovered hormone ghrelin, which is secreted from the stomach during fasting and hypoglycemia opposes the homeostatic functions of leptin by…”
Get full text
Journal Article -
14
Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Trafficking in Vitro
Published in The journal of clinical endocrinology and metabolism (01-02-2009)“…Objective: The clinically used somatostatin analogs, octreotide and lanreotide, act primarily by binding to somatostatin receptor 2 (sst2). In contrast, the…”
Get full text
Journal Article -
15
Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP
Published in American journal of physiology. Regulatory, integrative and comparative physiology (01-12-2001)“…Amylin is secreted with insulin from the pancreas during and after food intake. One of the most potent actions of amylin in vivo is its anorectic effect, which…”
Get more information
Journal Article -
16
Regulation of ghrelin secretion by somatostatin analogs in rats
Published in European journal of endocrinology (01-06-2005)“…Objective: Ghrelin is a hormone present in the plasma in two forms: octanoylated and des-octanoylated ghrelin. In pathophysiological conditions such as…”
Get full text
Journal Article -
17
Pasireotide (SOM230): Development, mechanism of action and potential applications
Published in Molecular and cellular endocrinology (14-05-2008)“…Pasireotide (SOM230) is a multi-receptor ligand somatostatin analogue with high binding affinity for somatostatin receptor subtypes sst 1,2,3 and sst 5…”
Get full text
Journal Article -
18
SOM230, A New Somatostatin Analogue, Is Highly Effective in the Therapy of Growth Hormone/Prolactin-Secreting Pituitary Adenomas
Published in Clinical cancer research (01-05-2007)“…Purpose: We have previously shown that transgenic mice ubiquitously overexpressing the HMGA2 gene develop growth hormone/prolactin-secreting pituitary…”
Get full text
Journal Article -
19
SOM230: a new therapeutic modality for Cushing's disease
Published in Chimia (01-01-2014)“…A rational drug design approach involving transposition of functional groups from SRIF into a reduced size cyclohexapeptide template has led to the discovery…”
Get full text
Journal Article -
20
Ectopic expression of Pax4 in pancreatic δ cells results in β-like cell neogenesis
Published in The Journal of cell biology (04-12-2017)“…The recent demonstration that pancreatic α cells can be continuously regenerated and converted into β-like cells upon ectopic expression of opened new avenues…”
Get full text
Journal Article